Research

Research

US FDA Approves Bristol Myers Squibb’s Reblozyl as First-Line Treatment of Anemia in Adults with Lower-Risk Myelodysplastic Syndromes

• Posted onSeptember 6, 2023 Last Updated: September 6, 2023
• By: Kaitlyn Grosse

Research

Seagen’s Breast Cancer Therapy Succeeds in Late-Stage Study

• Posted onAugust 30, 2023
• By: Kaitlyn Grosse

Research

Cocrystal Pharma, Founded by Nobel Prize Winner, Plans Human Tests for Experimental COVID-19 Drug

• Posted onAugust 16, 2023
• By: Kaitlyn Grosse

Research

New Test Might Expand Ability to Find Tumor Cells in Blood

• Posted onJuly 5, 2023
• By: Kaitlyn Grosse

Research

Seagen Touts Adcetris Early-Stage Lymphoma Data with 93% Complete Remission

• Posted onJune 27, 2023
• By: Kaitlyn Grosse

Research

Are We on the Cusp of a Breast Cancer Vaccine?

• Posted onFebruary 14, 2023 Last Updated: February 16, 2023
• By: Kaitlyn Grosse

Research

Four Years In, Sana Gets First FDA Go-Ahead to Bring Cancer Treatment Into The Clinic

• Posted onFebruary 1, 2023 Last Updated: February 1, 2023
• By: Kaitlyn Grosse

Research

Peering Deep into the Cellular Universe: Allen Institute Researchers Map Cell Parts in 3D

• Posted onJanuary 24, 2023 Last Updated: January 24, 2023
• By: Kaitlyn Grosse

Research

To Fight Opioid Crisis, UW Researchers Take New Shot at Developing Vaccine Against Addictive Drugs

• Posted onJanuary 10, 2022 Last Updated: January 10, 2022
• By: Kaitlyn Grosse

News

Seattle Startup Chases Alzheimer’s with $23 Million Series A

• Posted onJanuary 18, 2021 Last Updated: February 27, 2023
• By: Craig Mathews